Business Standard

Thursday, January 09, 2025 | 12:42 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA

The USFDA had imposed an import ban on the Halol plant in December 2015 too

Sun Pharma
Premium

The USFDA has excluded 14 products from the import alert subject to certain conditions, said Sun, the eighth largest pharmaceutical company in the US generics market.

Sohini Das Mumbai
The Halol facility of Sun Pharmaceuticals, the eighth-largest pharma company in the US generics market, was slapped with an import alert by the US Food and Drug Administration (USFDA), which could result in shipments from the Gujarat plant being refused entry into the USA.

As a result, analysts expect a 2-3 per cent hit to the firm’s top line and a 5-6 percent impact on its earnings before interest, taxes, depreciation, and amortisation (Ebitda).

On Thursday, the company’s stock took a beating, declining 3.57 per cent on the BSE. The USFDA had imposed an import ban on the Halol plant

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in